Mary Kay Harper
University of Utah
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Mary Kay Harper.
Journal of Experimental Marine Biology and Ecology | 1988
Joseph R. Pawlik; Michael R. Kernan; Tadeusz F. Molinski; Mary Kay Harper; D. John Faulkner
Abstract The Spanish dancer nudibranch Hexabranchus sanguineus (Ruppell et Leuckart), a large brightly colored shell-less sea slug (Gastropoda : Opisthobranchia) common to Indo-Pacific coral reefs, derives a potent chemical defense from a sponge that it eats ( Halichondria sp.). In turn, the nudibranch passes defensive compounds to its egg ribbons, which are similarly conspicuous and physically defenseless. Slices of the dorsal mantle tissue of the nudibranch were rejected in laboratory feeding assays employing two common sympatric predators: an Indo-Pacific reef fish, Thalassoma lunare (Linnaeus), and a reef hermit crab, Dardanus megistos (Herbst). The defensive metabolites, a suite of unusual oxazole-containing macrolides, were isolated from the sponge, the nudibranch, and the nudibranch egg masses at 0.14–0.38, 0.14–0.62, and 2.65% of dry weight, respectively, and were effective inhibitors of feeding by T. lunare at minimum concentrations of 0.01–0.02% dry weight of food pellet. The macrolides were concentrated in the dorsal mantle of the nudibranch, which is most vulnerable to predatory attack, and in the combined digestive gland/gonad, site of both sponge digestion and egg production. The most abundant macrolide in the sponge tissue was not present in the nudibranch or its egg masses, suggesting that chemical modification of this compound takes place upon digestion. In a reef environment dominated by visually oriented predators, the striking color pattern and behavioral responses of Hexabranchus may have arisen with a concomitant elaboration of dietarily derived chemical defenses.
Journal of Cell Science | 2010
Gary S. Coombs; Jia Yu; Claire A. Canning; Charles A. Veltri; Tracy M. Covey; Jit Kong Cheong; Velani Utomo; Nikhil Banerjee; Zong Hong Zhang; Raquel C. Jadulco; Gisela P. Concepcion; Tim S. Bugni; Mary Kay Harper; Ivana Mihalek; C. Michael Jones; Chris M. Ireland; David M. Virshup
Wnt proteins are secreted post-translationally modified proteins that signal locally to regulate development and proliferation. The production of bioactive Wnts requires a number of dedicated factors in the secreting cell whose coordinated functions are not fully understood. A screen for small molecules identified inhibitors of vacuolar acidification as potent inhibitors of Wnt secretion. Inhibition of the V-ATPase or disruption of vacuolar pH gradients by diverse drugs potently inhibited Wnt/β-catenin signaling both in cultured human cells and in vivo, and impaired Wnt-regulated convergent extension movements in Xenopus embryos. WNT secretion requires its binding to the carrier protein wntless (WLS); we find that WLS is ER-resident in human cells and WNT3A binding to WLS requires PORCN-dependent lipid modification of WNT3A at serine 209. Inhibition of vacuolar acidification results in accumulation of the WNT3A–WLS complex both in cells and at the plasma membrane. Modeling predictions suggest that WLS has a lipid-binding β-barrel that is similar to the lipocalin-family fold. We propose that WLS binds Wnts in part through a lipid-binding domain, and that vacuolar acidification is required to release palmitoylated WNT3A from WLS in secretory vesicles, possibly to facilitate transfer of WNT3A to a soluble carrier protein.
Journal of Natural Products | 2008
Tim S. Bugni; Burt Richards; Leen Bhoite; Daniel Cimbora; Mary Kay Harper; Chris M. Ireland
There is a need for diverse molecular libraries for phenotype-selective and high-throughput screening. To make marine natural products (MNPs) more amenable to newer screening paradigms and shorten discovery time lines, we have created an MNP library characterized online using MS. To test the potential of the library, we screened a subset of the library in a phenotype-selective screen to identify compounds that inhibited the growth of BRCA2-deficient cells.
Journal of Biomolecular Screening | 2011
Qun Li; Chaoyu Chen; Amit Kapadia; Qiong Zhou; Mary Kay Harper; Jerome Schaack; Daniel V. LaBarbera
Despite advancements in therapies developed for the treatment of cancer, patient prognosis and mortality rates have improved minimally, and metastasis remains the primary cause of cancer mortality worldwide. An underlying mechanism promoting metastasis in many types of cancer is epithelial-mesenchymal transition (EMT). Here the authors report a novel 3D model of EMT and metastatic breast cancer suitable for high-throughput screening (HTS) drug discovery. The primary assay incorporates the expression of the prognostic biomarker vimentin, as a luciferase reporter of EMT, in basil-like/triple-negative MDA-MB-231 breast carcinoma spheroids. Using this model, the authors developed a number of known antitumor agents as control modulators of EMT. U0126, PKC412, PF2341066, dasatinib, and axitinib downregulated vimentin expression by 70% to 90% as compared to untreated spheroids. Counterassays were developed to measure spheroid viability and the invasive potential of MDA-MB-231 spheroids after small-molecule treatment and used to confirm hits from primary screening. Finally, the authors conducted a pilot screen to validate this model for HTS using a purified library of marine secondary metabolites. From 230 compounds screened, they obtained a Z′ score of 0.64, indicative of an excellent assay, and confirmed 4 hits, including isonaamidine B, papuamine, mycalolide E, and jaspamide. This HTS model demonstrates the potential to identify small-molecule modulators of EMT that could be used to discover novel antimetastatic agents for the treatment of cancer.
ChemBioChem | 2006
Matthew D. Alexander; Michael D. Burkart; Michael S. Leonard; Padma Portonovo; Bo Liang; Xiaobin Ding; Madeleine M. Joullié; Brian M. Gulledge; James Aggen; A. Richard Chamberlin; Joel S. Sandler; William Fenical; Jian Cui; Santosh J. Gharpure; Alexei Polosukhin; Hai Ren Zhang; P. Andrew Evans; Adam D. Richardson; Mary Kay Harper; Chris M. Ireland; Binh G. Vong; Thomas P. Brady; Emmanuel A. Theodorakis; James J. La Clair
A Central Strategy for Converting Natural Products into Fluorescent Probes Matthew D. Alexander, Michael D. Burkart, Michael S. Leonard, Padma Portonovo, Bo Liang, Xiaobin Ding, Madeleine M. Joulli!, Brian M. Gulledge, James B. Aggen, A. Richard Chamberlin, Joel Sandler, William Fenical, Jian Cui, Santosh J. Gharpure, Alexei Polosukhin, Hai-Ren Zhang, P. Andrew Evans, Adam D. Richardson, Mary Kay Harper, Chris M. Ireland, Binh G. Vong, Thomas P. Brady, Emmanuel A. Theodorakis, and James J. La Clair*
Journal of Natural Products | 2003
Melissa L. Lerch; Mary Kay Harper; D. John Faulkner
Five novel brominated polyacetylenic diols, diplynes A-E (2-6), and three sulfated analogues, diplyne A 1-sulfate (7), diplyne C 1-sulfate (8), and 2-deoxydiplyne D sulfate (9), were isolated from the Philippines sponge Diplastrella sp. by employing bioassay-guided fractionation using the HIV-1 integrase inhibition assay. The novel metabolites were characterized by interpretation of spectroscopic data.
Tetrahedron Letters | 1988
Eoin Fahy; Tadeusz F. Molinski; Mary Kay Harper; Brian W. Sullivan; D. John Faulkner; László Párkányi; Jon Clardy
Abstract The marine sponge Haliclona sp. from Palau contains haliclonadiamine ( 2 ) as the major antimicrobial alkaloid, together with papuamine ( 1 ). The structure of haliclonadiamine ( 2 ) was determined by X-ray analysis.
Bioorganic & Medicinal Chemistry | 2009
Malcolm W.B. McCulloch; Gary S. Coombs; Nikhil Banerjee; Tim S. Bugni; Kendell M. Cannon; Mary Kay Harper; Charles A. Veltri; David M. Virshup; Chris M. Ireland
The Wnt signaling pathway regulates cell growth and development in metazoans, and is therefore of interest for drug discovery. By screening a library of 5808 pre-fractionated marine extracts in a cell-based Wnt signaling assay, several signaling activators and inhibitors were observed. LCMS-based fractionation rapidly identified an active compound from Pseudoceratina purpurea as psammaplin A, a known HDAC inhibitor. Other HDAC inhibitors similarly activated signaling in this assay, indicating HDAC inhibitors will be identified through many cell-based reporter assays. In a large scale analysis of P. purpurea, three previously undescribed bromotyrosine based natural products were identified; the structure of one of these was confirmed by synthesis. Additionally, three other derivatives of psammaplin A were prepared: a mixed disulfide and two sulfinate esters. Finally, evidence to support a structural reassignment of psammaplin I from a sulfone to the isomeric sulfinate ester is presented.
Molecules | 2008
Tim S. Bugni; Mary Kay Harper; Malcolm W.B. McCulloch; Jason Reppart; Chris M. Ireland
The high-throughput screening and drug discovery paradigm has necessitated a change in preparation of natural product samples for screening programs. In an attempt to improve the quality of marine natural products samples for screening, several fractionation strategies were investigated. The final method used HP20SS as a solid support to effectively desalt extracts and fractionate the organic components. Additionally, methods to integrate an automated LCMS fractionation approach to shorten discovery time lines have been implemented.
Journal of Natural Products | 2011
Zhenyu Lu; Ryan M. Van Wagoner; Mary Kay Harper; Heather L. Baker; John N. A. Hooper; Carole A. Bewley; Chris M. Ireland
Four new depsipeptides, mirabamides E-H (1-4), and the known depsipeptide mirabamide C (5) have been isolated from the sponge Stelletta clavosa, collected from the Torres Strait. The planar structures were determined on the basis of extensive 1D and 2D NMR and HRESIMS. The absolute configurations were established by the advanced Marfeys method, NMR, and GC-MS. The four new compounds all showed strong inhibition of HIV-1 in a neutralization assay with IC(50) values of 121, 62, 68, and 41 nM, respectively.